Testing and integrating the WLCG/EGEE middleware in the LHC computing

The main goal of the Experiment Integration and Support (EIS) team in WLCG is to help the LHC experiments with using proficiently the gLite middleware as part of their computing framework. This contribution gives an overview of the activities of the EIS team, and focuses on a few of them particularly important for the experiments. One activity is the evaluation of the gLite workload management system (WMS) to assess its adequacy for the needs of the LHC computing in terms of functionality, reliability and scalability. We describe in detail how the experiment requirements can be mapped to validation criteria, and the WMS performances are accurately measured under realistic load conditions over prolonged periods of time. Another activity is the integration of the Service Availability Monitoring system (SAM) with the experiment monitoring framework. The SAM system is widely used in the EGEE operations to identify malfunctions in Grid services, but it can be adapted to perform the same function on experiment-specific services. We describe how this has been done for some LHC experiments, which are now using SAM as part of their operations

Antiviral activity of fecal water samples from HIV-1 infected subjects treated with a specific probiotic formulation

Objectives: The aim of the study was to investigate if the supplementation with multistrain probiotics may be able to modulate T cell response in HIV-1 infected patients and to evaluate the anti-HIV activity of probiotic by studying fecal water (FW) samples. Methods: Three HIV-1-positive patients (Pt1, Pt2 and Pt3) on long-term suppressive combined antiretroviral therapy (cART) received a specific multi-strain probiotic supplementation (Vivomixx ®), for six months (T6). Levels of T cell subsets were evaluated by flow cytometry. Anti- HIV activity of FW samples was evaluated in vitro. Results: CD4+ T cells levels increased in all HIV-1 infected patients whereas activation markers (CD38 and HLA-DR) were decreased both on CD4+ and CD8+ T cells. FW samples presented an increased inhibitory activity against HIV-1 compared to T0 (FW-Pt1: T0 =40%, T6 = 65% of reduction; FW Pt2: T0 = 26%, T6 = 46% of reduction; FW Pt3: T0 = 47%, T6 = 94% of reduction). Discussion: Our data suggest that the administration of the specific probiotic formulation improves the antiviral status of people living with HIV-1 under cART, also modulating T cell response. Conclusion: Anti-HIV activity of FW may have several public health and social implications for sexually transmitted diseases that need to be further explored

Morfología valvar de Didymosphenia geminata (Bacillariophyceae) de las provincias de Santa Cruz y Tierra del Fuego, Patagonia, Argentina.

Background and aims: In 2013, blooms similar to those produced by Didymosphenia geminata (Lyngbye) M. Schmidt around the world, were detected in the Grande River basin, Tierra del Fuego province, and in 2014 in de las Vueltas River in Santa Cruz province. The aim of this paper is to analyze the valve morphology and morphometry of these materials to establish if they correspond to D. geminata or to other species of the genus that is producing the massive growth in southern Patagonia. M&M: Samples were collected at Grande River in 2013 and 2015 and, in de las Vueltas River in 2015 and 2016. Samples were analyzed with light and electron microscopy. For morphometric analyses 100 specimens from each sample were measured and statistical analyses were carried out using the R statistical package. Results: The studied populations have the same fine morphology described for other populations collected in Patagonia. Nevertheless, in some sampling sites from Santa Cruz province, we found a morphotype with a markedly smaller size, subcapitated poles, little marked constrictions of the poles, a broad central area (relative to cell size) and 1 to 3 stigmata, that was never reported in South America. Conclusions: The studied populations correspond to D. geminata ssp. geminata Metzeltin & Lange-Bertalot. From a morphological point of view the smaller morphotype present in Santa Cruz belongs to the same subspecies but can be easily misidentified during the routine monitoring programs carried out with light microscope due its size and valve outline.Introducción y objetivos: En 2013 floraciones similares a las producidas por Didymosphenia geminata (Lyngbye) M. Schmidt en distintos lugares del mundo fueron detectadas en la Cuenca del Río Grande, provincia de Tierra del Fuego y, en 2014 en el río de las Vueltas en la provincia de Santa Cruz. El objetivo del trabajo fue analizar la morfología y morfometría valvar de estos materiales para establecer si corresponden a D. geminata o a otra especie del género que está produciendo floraciones masivas en la Patagonia sur.  M&M: Las muestras fueron colectadas en el Río Grande en 2013 y 2015 y en el Río de las Vueltas en 2015 y 2016. El material fue analizado con microscopía óptica y electrónica. Para los análisis morfométricos fueron medidos 100 especímenes por muestra y los análisis estadísticos fueron llevados a cabo con el programa estadístico R. Resultados: Las poblaciones estudiadas presentan las mismas características morfológicas descriptas para poblaciones de distintos lugares de Patagonia. Sin embargo, en Santa Cruz observamos un morfotipo marcadamente más pequeño, con polos subcapitados, constricción suavemente marcada, un área central amplia  con 1 a 3 estigmas, que no había sido descripto antes para Sudamérica.   Conclusiones: Las poblaciones estudiadas corresponden a D. geminata ssp. geminata Metzeltin & Lange-Bertalot. Desde un punto de vista morfológico, los especímenes pequeños presentes en Santa Cruz pertenecen a la misma subespecie pero por su tamaño y contorno valvar pueden ser confundidos con otros taxones durante los programas de monitoreo llevados a cabo con microscopía óptica.

Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation Electroanatomic characterization and treatment

ObjectivesThe purpose of this study was to evaluate the electroanatomic characteristics of left atrial tachycardia (AT) in a series of patients who underwent circumferential pulmonary vein ablation (CPVA) and to describe the ablation strategy and clinical outcome.BackgroundCircumferential pulmonary vein ablation is an effective treatment for atrial fibrillation. A potential midterm complication is the development of left AT. There are only isolated reports describing mapping and ablation of such arrhythmias.MethodsThirteen patients (age 57.4 ± 8.9 years, five female) underwent mapping and ablation of 14 left ATs via an electroanatomic mapping system a mean of 2.6 ± 1.6 months after CPVA.ResultsThree patients were characterized as having focal AT (cycle length: 266 ± 35.9 ms). Of 11 macro–re-entrant tachycardias studied in the remaining 10 patients (cycle length: 275 ± 75 ms), 5 showed single-loop and 6 dual-loop circuits. Re-entrant circuits used the mitral isthmus, the posterior wall, or gaps on previous encircling lines. Such gaps and all three foci occurred anterior to the left superior pulmonary vein or at the septal aspect of the right pulmonary veins. Thirteen of 14 tachycardias (93%) were successfully ablated.ConclusionsLeft AT after CPVA can be due to a macro–re-entrant or focal mechanism. Re-entry occurs most commonly across the mitral isthmus, the posterior wall, or gaps on previous ablation lines. Such gaps and foci occur most commonly at the anterior aspect of the left superior pulmonary vein and at the septal aspect of the right pulmonary veins. These arrhythmias can be successfully mapped and ablated with an electroanatomic mapping system

Preliminary attempt to predict risk of invasive pulmonary aspergillosis in patients with influenza. Decision trees may help?

Invasive pulmonary aspergillosis (IPA) is typically considered a disease of immunocompromised patients, but, recently, many cases have been reported in patients without typical risk factors. The aim of our study is to develop a risk predictive model for IPA through machine learning techniques (decision trees) in patients with influenza. We conducted a retrospective observational study analyzing data regarding patients diagnosed with influenza hospitalized at the University Hospital “Umberto I” of Rome during the 2018-2019 season. We collected five IPA cases out of 77 influenza patients. Although the small sample size is a limit, the most vulnerable patients among the influenza-infected population seem to be those with evidence of lymphocytopenia and those that received corticosteroid therapy

Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations.

Background: Triple-negative breast cancers (TNBC) are characterized by aggressive tumour biology resulting in a poor prognosis. Androgen receptor (AR) is one of newly emerging biomarker in TNBC. In recent years, ARs have been demonstrated to play an important role in the genesis and in the development of breast cancer, although their prognostic role is still debated. In the present study, we explored the correlation of AR expression with clinical, pathological and molecular features and its impact on prognosis in early TNBC. Patients and Methods: ARs were considered positive in case of tumors with >10% nuclear-stained. Survival distribution was estimated by the Kaplan Meier method. The univariate and multivariate analyses were performed. The difference among variables were calculated by chi-square test. Results: 81 TNBC patients diagnosed between January 2006 and December 2011 were included in the analysis. Slides were stained immunohistochemically for estrogen and progesterone receptors, HER-2, Ki-67, ALDH1, e-cadherin and AR. Of the 81 TNBC samples, 18.8% showed positive immunostaining for AR, 23.5% and 44.4% of patients were negative for e-cadherin and ALDH1, respectively. Positive AR immunostaining was inversely correlated with a higher Ki-67 (p < 0.0001) and a lympho-vascular invasion (p = 0.01), but no other variables. Univariate survival analysis revealed that AR expression was not associated with disease-free survival (p = 0.72) or overall survival (p = 0.93). Conclusions: The expression of AR is associated with some biological features of TNBC, such as Ki-67 and lympho-vascular invasion; nevertheless the prognostic significance of AR was not documented in our analysis. However, since ARs are expressed in a significant number of TNBC, prospective studies in order to determine the biological mechanisms and their potential role as novel treatment target

Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients

Long COVID refers to patients with symptoms as fatigue, “brain fog,” pain, suggesting the chronic involvement of the central nervous system (CNS) in COVID-19. The supplementation with probiotic (OB) would have a positive effect on metabolic homeostasis, negatively impacting the occurrence of symptoms related to the CNS after hospital discharge. On a total of 58 patients hospitalized for COVID-19, 24 (41.4%) received OB during hospitalization (OB+) while 34 (58.6%) taken only the standard treatment (OB–). Serum metabolomic profiling of patients has been performed at both hospital acceptance (T0) and discharge (T1). Six months after discharge, fatigue perceived by participants was assessed by administrating the Fatigue Assessment Scale. 70.7%of participants reported fatigue while 29.3%were negative for such condition. The OB+ group showed a significantly lower proportion of subjects reporting fatigue than the OB– one (p < 0.01). Furthermore, OB+ subjects were characterized by significantly increased concentrations of serum Arginine, Asparagine, Lactate opposite to lower levels of 3-Hydroxyisobutirate than those not treated with probiotics. Our results strongly suggest that in COVID-19, the administration of probiotics during hospitalization may prevent the development of chronic fatigue by impacting key metabolites involved in the utilization of glucose as well as in energy pathways

Oral bacteriotherapy in patients with COVID-19: a retrospective cohort study

Background: Mounting evidence suggests SARS-CoV-2 may impact on host microbiota and gut inflammation, infecting intestinal epithelial cells. This possible link and its implications can be investigated by observing the effects of modulation of the microbial flora in patients with COVID-19. The aim of this study was to compare the rate of mortality, the need of ICU hospitalization and the length of hospitalization in patients with severe COVID-19 pneumonia who received the best available therapy (BAT) vs. patients treated with BAT and supplemented with oral bacteriotherapy. Methods: This retrospective, observational cohort study included 200 adults with severe COVID-19 pneumonia. All patients received therapeutic regimens including low molecular weight heparin plus one or more between hydroxychloroquine, azithromycin, antivirals, and Tocilizumab. Oral bacteriotherapy was used as complementary treatment. Results: Out of the 200 patients, 112 received BAT without oral bacteriotherapy, and 88 BAT with oral bacteriotherapy. Crude mortality was 22%. Eleven percent died in the group of patients treated with BAT plus oral bacteriotherapy vs. 30% subjects in the group of patients managed only with BAT (p < 0.001). By multivariate analysis, the age >65 years, CRP >41.8 mg/L, Platelets <150.000 mmc, and cardiovascular events were associated with the increased risk of mortality. Oral bacteriotherapy was an independent variable associated with a reduced risk for death. Despite large prospective trials are needed, this study highlights a possible role for oral bacteriotherapy in the management of patients hospitalized for COVID-19 pneumonia